Page 3 - Best Adenoid Removal doctors: TOP 59 doctors

Prof. Dr. Ali Vefa YÜCETÜRK was born in Aydın in 1963. He graduated from Hakimiyetimilliye Primary School in 1974, Izmir Private Turkish High School in 1980, and graduated from Ege University Faculty of Medicine in 1986.

After completing his compulsory service at Adıyaman's Çelikhan District Health Center in 1986-89, he specialized in Ear Nose and Throat Diseases at Karadeniz Technical University Faculty of Medicine between 1989-92 and worked in the same clinic as a specialist until 1994. KKK in 1993. He did his military service at Izmir Military Hospital.

He started working as an ENT faculty member at Celal Bayar University Faculty of Medicine in 1994, and became an associate professor in 1999 and a professor in 2005.

In 1996, he carried out studies and research on larynx and parotid surgery at the ENT Clinic of the University of Ferrara, Italy, with Prof. Dr. Carlo Calearo and Prof. Dr. Antonio Pastore.

He is a member of the Turkish Otorhinolaryngology and Head and Neck Surgery Association and the Laryngology Association.

He supervised four theses on laryngeal cancer, inner ear hearing loss and snoring-sleep apnea.

He participated in more than 40 congresses, courses and meetings at home and abroad as a speaker and participant.

He has 18 scientific articles published in international and 31 national journals, 11 international and 35 papers presented in national meetings, and 5 copyrighted book chapters. In particular, his studies on snoring, obstructive sleep apnea, voice diseases, laryngeal cancer and ear microsurgery have been at the forefront.

2013

Istanbul Florence Nightingale Hospital

Ear Nose Throat

1998 - 2013

Istanbul Surgery Hospital

Ear Nose Throat

1996 - 1997

Şişli Etfal Hospital

ENT Assistant Chief

1992 - 1996

Indiana Methodist Hospital

Ear Nose Throat

1992 - 1996

Institut Gustave Roussy, France

Observer Physician

1992 - 1995

Clinic of Professeur Frederic Chabolle at Suresnes Hopital Foch

Assistant Physician

1989 - 1992

Şişli Etfal Hospital

ENT Chief Assistant

1985 - 1989

Şişli Etfal and Marmara University Hospital

ENT Specialization

He was born in France in 1969. After graduating from İzmir Müdafaai Hukuk Primary School and Bornova Anatolian High School, he entered Ege University Faculty of Medicine. After completing his specialization at Celal Bayar University Faculty of Medicine Ear Nose and Throat Clinic, he worked as Op.Dr. Together with Denizhan Özkaya, he founded ENTO Ear, Nose and Throat in Alsancak.

Op.Dr., who worked as a visiting doctor at the Ear Nose and Throat Clinic of the University of Vienna, Austria, in 1998. Ümit Filiz speaks English and German.

He is a member of the Turkish Ear Nose Throat Head and Neck Surgery Association, the Turkish Ear Nose Throat Head and Neck Surgery Foundation, the Turkish ENT Facial Plastic Surgery Working Group, the Turkish Sleep Research Association and the European Sleep Research Association Aviation Medical Association.

He received the “Flight Medicine” certificate at the Eskişehir Aerospace Medicine Physiological Training Course within the Air Force (8 October – 16 November 2001). Aesthetic and functional nose surgery, endoscopic sinus surgeries and snoring and apnea surgery are his special areas of interest.

After he completed his University in Dicle University Medical Faculty, he has specialized in ENT Clinic in Izmir Education and Reseacrh Hospital. Following he worked in Aydin Medline Hospital as ENT Specialist. Since May 2012 he began working at Private ENTO ENT Medical Center and still continue to work there.He is a highly skilled specialist in the treatment of protruding ears (otoplasty) and a broad range of related ear conditions. With a deep understanding of ear anatomy and aesthetics, he is adept at correcting prominent ears, providing solutions that balance cosmetic appeal with functional outcomes. His expertise extends to the diagnosis and management of congenital ear deformities such as microtia and lop ear, as well as addressing ear trauma, keloid formation after ear piercings, and chronic ear infections that may affect both children and adults. He is committed to offering comprehensive and personalized care, utilizing advanced surgical techniques and non-surgical options to ensure optimal results for his patients. His approach is patient-centered, focusing on delivering the highest standard of care with a dedication to improving both the appearance and overall ear health of his patients.

Igor Anurin - medical specialist (according to the qualification system of doctors in Poland and the European Union), a doctor of the highest category with seventeen years of experience in leading clinics in Warsaw. He specializes in endoscopic sinus surgery, nasal septum straightening, rhinoplasty, plastic surgery of the soft palate (treatment of snoring and sleep apnea), salivary gland tumors, treatment and diagnosis of head and neck cancer, as well as outpatient treatment of acute and chronic diseases of the upper respiratory tract. In addition, Dr. Anurin is a member of the Polish Society of Otolaryngologists and Head and Neck Surgeons. He regularly participates in international scientific and practical conferences in otorhinolaryngology. Dr. Igor Anurin lives in Warsaw. 

Currently, he is a leading surgeon in the ENT department at the Mazowiecki Bródnowski Hospital. He is the head of the emergency department and head of the resident specialization. At Mea Clinic, he conducts consultations and performs surgeries. For several years, a large group of his patients have been Russian-speaking patients. FESS (functional endoscopic sinus surgery) is a surgical technique involving minimally invasive surgical drainage of the paranasal sinuses. It involves intranasal opening of narrow spaces responsible for the development of chronic sinusitis and for the process of their mucociliary cleansing. Mucosal overgrowths, polyps, and small bone structures occurring in functionally unfavorable anatomical variants are removed. Another goal of the FESS operation is to open the sinuses in the most atraumatic way possible. The procedure lasts from 45 minutes to 2 hours, depending on the extent of the surgical procedure performed.

Academic and Professional Background

• Education:
  • 1990–1996: Hacettepe University Faculty of Medicine (MD).
  • 1996–2000: Residency in ENT at Ankara Training and Research Hospital.
  • 2002: Advanced training at the House Ear Institute, Los Angeles, USA.
• Professional Experience:
  • Various roles including researcher, specialist, and chief at prominent hospitals in Turkey.
  • Since 2011: Professor at Lokman Hekim Health Group, focusing on ENT diseases.

Key Achievements and Research Contributions

• Published Work:
  • Over 30 scientific articles in international journals on ENT topics such as hearing loss, laryngeal cancer, and sinus conditions.
  • Topics include rare diseases, surgical innovations, and radiological evaluations.
  • Co-author of ENT-related books and translated chapters in notable surgical references.
• Conference Presentations:
  • Frequent presenter at national and international scientific meetings.
  • Delivered groundbreaking studies on cochlear implants, paranasal tumors, and hearing aid effects on geriatric tinnitus.
• Awards & Recognition:
  • Recognized for excellence in clinical practice and surgical training models, particularly in stapedectomy.

Clinical and Research Interests

• Diseases of the ear, nose, and throat, with a focus on: 
  • Hearing disorders (sensorineural, conductive, age-related).
  • Rhinological conditions, including sinusitis and mucosal pathologies.
  • Oncological ENT cases, specifically rare cancers of the larynx and paranasal sinuses.

International Training and Professional Development

• Attended multiple specialized courses at the House Ear Institute (USA) focusing on temporal bone surgery and pathology.
• Participation in advanced workshops and conferences such as the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF).

Publications and Citations

• Authored high-impact studies cited in prominent journals.
• Contributions to understanding ENT disorders through innovative research methods, such as temporal bone dissection and immunohistochemistry.

Prof. Dr. Celil Göçer is a distinguished ENT specialist whose extensive clinical expertise and academic contributions have greatly influenced the field. He is highly regarded for his innovative surgical approaches and dedication to advancing medical knowledge.

Education & Training

ENT Specialization, Fatih Sultan Mehmet Training and Research Hospital, 1996

Marmara University Faculty of Medicine, Istanbul, Turkey, 1990

Professional Experience

Specialist, Ear, Nose & Throat, Büyük Anadolu Hospitals, 2005 - Present

Completed military service as a specialist at Eskişehir Military Air Hospital, 2004

Specialist, Istinye State Hospital & Haydarpaşa Training and Research Hospital, Ministry of Health, Turkey, 2004

Areas of Expertise

Rhinoplasty (Nose Aesthetic Surgery, Closed Technique)

Septoplasty (Nasal Septum Correction for better airflow)

Sleep Apnea Surgery Dr. Ilgın is widely regarded for his advanced techniques in the surgical treatment of sleep apnea, offering patients highly effective, tailored solutions to improve their quality of life and reduce the risks associated with sleep-disordered breathing.

Adenoidectomy (Removal of the Adenoids)

Tonsillectomy (Tonsil Removal) using the Thermal Welding Method

Ear Tube Insertion (to treat recurrent ear infections and fluid buildup)

Tympanoplasty (Eardrum Repair Surgery)

Functional Endoscopic Sinus Surgery (FESS) (For Sinusitis and Polyps)

Salivary Gland Surgery

I. Publications in International Journals

A. Experimental Studies

Doner F, Delibas N, Dogru H, Sari I, Yorgancigil B. Malondialdehyde Levels and Superoxide Dismutase Activity in Experimental Maxillary Sinusitis. Auris Nasus Larynx. 1999; 26(3): 287-91.

Döner F, Delibaş N, Dogru H, Yarıktaş M, Demirci M. The Role of Free Oxygen Radicals in Experimental Otitis Media. J Basis Clin Physiol Pharmacol. 2002; 13: 33-40.

Tuz M, Eroglu E, Dogru H, Delibas N, Tunc B, Uygur K. The Effect of Replacement Fluids and Normovolemic Hemodilution on the Survival of Dorsal Skin Flaps in Rats. Clin Otolaryngol. 2004; 29(1): 80-83.

Yarıktas M, Doner F, Ozguner F, Gokalp O, Dogru H, Delibas N. Nitric Oxide Level in the Nasal and Sinus Mucosa After Exposure to Electromagnetic Field. Otolaryngology-Head and Neck Surgery. 2004.

Dr. Doğukan Aydenizöz Clinic in Antalya is a trusted destination for
advanced ear, nose, and throat (ENT) care, as well as facial aesthetic
treatments. Dr. Aydenizöz graduated from Afyon Kocatepe University
Faculty of Medicine in 2016 and completed his ENT speciality training
at Antalya Training and Research Hospital in 2022. He has since
established himself as a respected surgeon, known for his precision,
clear communication, and patient-centred approach.

With over nine years of experience, Dr. Aydenizöz offers a
comprehensive range of services including functional and aesthetic
rhinoplasty, septoplasty, endoscopic sinus surgery, treatment for
snoring and sleep apnea, eyelid aesthetics, and non-surgical facial
rejuvenation with anti-wrinkle treatment and fillers. His clinic
focuses on combining functional health with natural-looking aesthetic
results.

Previously, Dr. Aydenizöz served in Dinar State Hospital and Sinanpaşa
Community Health Centre. He now works as a senior ENT and facial
aesthetics specialist at the Medical Park Antalya Hospital Complex. He
is an active member of the Antalya Medical Chamber and the Turkish
Facial Plastic Surgery Association and regularly participates in
national and international medical congresses.

Patients appreciate his calm and informative demeanour, as well as the
clinic’s warm environment, modern facilities, and high standards of
hygiene and professionalism. Whether seeking treatment for a medical
ENT condition or a cosmetic enhancement, Dr. Aydenizöz ensures each
patient receives personalised care tailored to their needs and
expectations.

Education & Expertise

1981 to 1987 | Gülhane Military Medical Academy Faculty of Medicine

October 1990 to December 1993 | GATA, Department of Ear, Nose, and Throat – Specialization

Professional Experience

October 1988 to September 1990 | 5th CORPS Headquarters Health Veterinary Section Chief – Compulsory Service, Çorlu

January 1994 to September 1994 | Sivas Military Hospital, Sivas

February 1995 to August 1998 | Halkbank Health Center, Ankara

August 1998 to August 1999 | SSK Ankara Training Hospital, Ankara

August 1999 to 2003 | Kırıkkale University Faculty of Medicine, ENT-BBC Department – Assistant Associate Professor

March 2003 to 2008 | Kırıkkale University Faculty of Medicine, ENT-BBC Department – Associate Professor

March 2008 to 2013 | Kırıkkale University Faculty of Medicine, ENT-BBC Department – Professor

March 2005 to September 2013 | KÜTF ENT-BBC Department Head

May 2010 to May 2013 | KÜTF, Faculty Board Member

December 2013 to December 2019 | Anadolu Health Center (Affiliated with Johns Hopkins Medicine)

December 2019 to December 2020 | Break Abroad

Foreign Experience

July, 1991 | Free University Hospital, Dept. of Otolaryngology - Division of Head and Neck Surgery, Amsterdam, Netherlands

May - July, 2002 | University of Michigan, Dept. of Otolaryngology - Division of Otology Neurotology, Ann Arbor, USA

July - August, 2009 | Sint Augustinus GZA Ziekenhuizen, Dept. of Otolaryngology - Division of Otology, Antwerp, Belgium

July, 2009 | International Neuroscience Institute, Hannover, Germany

July - August, 2012 | University of Pittsburgh, Dept. of Otolaryngology - Head and Surgery, Pittsburgh, USA

November, 2015 | Memorial Sloan-Kettering Cancer Center, Dept. of Head and Neck Oncology, New York, USA

August - September, 2016 | University of Toronto, Dept. of Otolaryngology - Head and Surgery, Toronto, Canada

November, 2018 | University of Toronto, Dept. of Otolaryngology - Head and Surgery, Toronto, Canada

Professional Memberships

-Turkish Ear Nose Throat and Head and Neck Surgery Association

-Association of Ear, Nose, and Throat and Head and Neck Surgery

-Turkish Rhinology Association

-Otology-Neurotology Association

-Facial Plastic Surgery Association

-Laryngology Association

Board Memberships & Leadership Roles

May 2010 to May 2012 | Member of the Board of Directors, Ear Nose Throat and Head and Neck Surgery Association

2008 to 2010 | Turkish Rhinology Association, General Rhinology Working Group Member

CURRICULUM VITAE

VOLKERT B. WREESMANN MD PhD

Consultant Otolaryngologist

Oncologic Head and Neck Surgeon

Thyroid and Parathyroid Surgeon

Facial Plastic Surgeon

Principal Positions

• Centro Medico Teknon, Barcelona, Spain

Chairman, Department of Otolaryngology-Head and Neck Surgery

July 1st 2024 – present

• Juaneda, Ciutadella Menorca, Spain

Consultant Otolaryngologist-Head and Neck Surgeon

January 2025 – present

• Avantmedic, Lleida, Spain

Consultant Otolaryngologist-Head and Neck Surgeon

July 1st 2024 – present

• Clinica Omega Zeta, Andorra

Consultant Otolaryngologist-Head and Neck Surgeon

March 1st 2022 – present

• University Hospitals Dorset NHS Foundation Trust

Consultant Otolaryngologist-Head and Neck Surgeon

August 1st 2021 – October 1st 2023

• Oxford University Hospitals NHS Foundation Trust

Honorary Consultant Otolaryngologist-Head and Neck Surgeon

May 1st 2021 – April 30th 2024

• Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Consultant Otolaryngologist-Head and Neck Surgeon

July 18th 2016 – April 30th 2021

• Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Consultant Otolaryngologist-Head and Neck Surgeon

November 7th 2015 – May 31st 2016

• Heart of England NHS Trust, Birmingham, UK

Consultant Otolaryngologist-Head and Neck Surgeon

March 1st 2015 – October 31st 2015

• University Medical Center Utrecht, Netherlands

Consultant Otolaryngologist-Head and Neck Surgeon

November 1st 2013 – June 1st 2014

Memberships

• American Head and Neck Society – Member

Netherlands Academy of Otolaryngology - Member

Professional Licences

• United Kingdom

GMC Certification

Fully Registered Medical Practitioner with Specialist Registration with a License to Practice

Registered: 02/02/2015

GMC # 7499626

• United States of America

New York State Department of Health

New York State Education Department

Registered: July 2011

License# P80949

Physician

• Netherlands

Dutch Ministry of Health (BIG Registration)

BIG Registered: 22-06-2005

BIG #19063373601

Physician

Dutch Specialist Board (RGS)

RGS registered: 01-02-2011

RGS #1911979

Otolaryngology-Head and Neck Surgeon

• Spain

Collegi de Metges de Barcelona

COMB: 63638

• Andorra

Collegi de Metges d’Andorra

RPS: 03098

COMA: 876

Education

• Memorial Sloan-Kettering Cancer Center

Surgical Fellowship, Head and Neck Surgery

New York, New York, USA

August 1st 2011 - July 31st 2013

600 bed dedicated cancer center

Performed 1200 major oncologic head and neck resections in 2 years

• United States of America ECFMG Certification

United States Medical Licensing Examination (USMLE)

Certification: June 22nd, 2010

Scores: 

   Step I: 244/99 

   Step IIa-Clinical knowledge: 227/94

   Step IIb-Clinical Skills: PASSED

   Step III: 206/85

• Netherlands Cancer Institute

Surgical Fellowship, Head and Neck Surgery

Amsterdam, The Netherlands

February 1st 2011 - July 31st 2011

Specialized Head and Neck Cancer Surgery Department

200 bed hospital

• Amsterdam University Medical Center/Netherlands Cancer Institute

Residency Training, Otolaryngology-Head and Neck Surgery

Amsterdam, the Netherlands

February 1st 2006 – January 31st 2011

• University of Amsterdam School of Medicine

Medical Doctor (MD)

Amsterdam, the Netherlands

December 2002 - January 28th 2005

• University of Amsterdam

Doctor of Philosophy (PhD), Molecular Biology

Amsterdam, the Netherlands

Thesis title: Molecular-cytogenetic characterization of head and neck cancer

December 2nd, 2004

• Erasmus University School of Medicine

Doctoral Degree in Medicine

Rotterdam, the Netherlands

September 1994 - November 17th, 1998

Research Training

• Memorial Sloan-Kettering Cancer Center

Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery, New York, New York, USA

Research Fellowship in Molecular Oncology

Supervisors: Dr. Bhuvanesh Singh MD, PhD and Dr. Jatin P. Shah, MD, FACS

March 1st 1999 - September 30st 2002

• University of California San Francisco (UCSF)

Department of Otolaryngology-Head and Neck Surgery, San Francisco, California, USA

Post-doctoral Research Fellowship in Head and Neck Oncology

Supervisors: Dr. Steven Wang MD And Prof David Eisele MD

February 2005 - January 2006

Academic Activities

University of Amsterdam

Doctorate Examination Committee member

• September 17th, 2013 - PhD Candidate: Dr. I.J. Nixon (United Kingdom)
• October 17th 2014 - PhD Candidate: Dr. J. Pramana (Netherlands)
• November 17th 2015 - PhD candidate: Dr. H. van Monsjou (Netherlands)
• December 11th 2018 - PhD Candidate: Dr. Tihana Ibrahimpasic (United States)
• January 18th, 2021 - PhD Candidate: Dr. Laura Wang (Australia)
• June 2nd, 2021 - PhD Candidate: Dr. Caroline Verhagen (Netherlands)

Conference Faculty

• Advanced Laryngopharyngeal Cancer: Functional Preservation and Rehabilitation, Portsmouth, June 25th - 26th, 2020 (postponed due to COVID) - Chairman
• Functional Preservation and Rehabilitation after Treatment for Advanced Laryngeal Cancer, Portsmouth, March 14th - 15th, 2019 - Chairman
• Portsmouth Parathyroid Conference, Portsmouth, December 14th 2018 – Chairman

Editorial Roles

• European Journal of Surgical Oncology

Associate Editor

January 1st 2023 – present

• European Journal of Surgical Oncology

Guest Editor

March issue 2018, Volume 44, Issue 3, p275-378 - Special issue on thyroid cancer management

• Journal of Oral Pathology and Medicine

Guest Editor

November issue 2021, Volume 51, Issue 10 - Special issue on vascular malformations and tumors of the head and neck

• Scientific Journal Reviewer

Oral Oncology, European Journal of Surgical Oncology, Journal of Surgical Oncology, Head and Neck, International Journal of Cancer

• Scientific Project and Grant Reviewer

Netherlands: Dutch Cancer Society

France: Institute National du Cancer

Awards

• New York Head and Neck Society

Annual Meeting, New York, NY, March 2002

Title of study presented: “MUC1 is a target if 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer”

Invited Lectures

• European Society of Surgical Oncology meeting, Krakow, 2016
• Barcelona Society of Neurosurgery, Annual Meeting, Baqueira, Spain, February, 2017
• University of Edinburgh, Department of Otolaryngology Academic Conference, March 17th 2017
• Medilex: Performance of Medical Specialists, Zeist, Netherlands, November 9th 2017
• Medilex: Performance of Medical Specialists, Driebergen, Netherlands, October 11th 2017
• Wessex Head and Neck and Thyroid Network Education Day, May 3rd, 2017
• Portsmouth Parathyroid Conference, Portsmouth, UK, December 14th 2018
• Global Post-laryngectomy Rehabilitation Academy, Portsmouth, UK, March 14th 2019
• Health Care Quality Conference, Beverwijk, Netherlands, March 25th, 2019

Published Research Reports

• The growing precision of diagnostic pathways in thyroid nodule evaluation. 

Bekker J, Wreesmann VB. 

Eur J Surg Oncol. 2025 Jan;51(1):109374.

• Special issue: Management of vascular tumors and malformations of the head and neck. 

Oomen KPQ, Brennan PA, Wreesmann VB. 

J Oral Pathol Med. 2022 Nov;51(10):829.

• Angiosarcomas of the head and neck: Impact of large data analysis on clinical management.
•  
• Wreesmann VB, Oomen KP, Brennan PA.

J Oral Pathol Med. 2022 Nov;51(10):904-910.

• Current classification of vascular anomalies of the head and neck. 

Oomen KPQ, Wreesmann VB. 

J Oral Pathol Med. 2022 Nov;51(10):830-836.

• A novel classification of carotid body tumors.

Wreesmann VB, Nixon IJ. 

Eur. J. Surg. Oncol. May, 2021

• Management of the contralateral central neck in differentiated thyroid cancer: A contentious issue. 

Shaha AR, Tuttle RM, Wreesmann VB. 

Eur. J. Surg. Oncol. 2021 Apr;47(4):717-719.

• Improvement of oral cancer screening quality and reach: The promise of artificial intelligence.
•  
• Kar A, Wreesmann VB, Shwetha V, Thakur S, Rao VUS, Arakeri G, Brennan PA.

J Oral Pathol Med. 2020 Mar 11

• The risk-benefit ratio of chemoradiation treatment in head and neck squamous cell carcinoma: value of extranodal spread and margin status. 

Ammar M, Wreesmann VB. 

Journal of ENT Masterclass, Yearbook 2018, Volume 11, Nr. 1, December 1st, 2018

• Nasal obstruction secondary to an inverted midline supernumerary tooth. 

Jones L, Hilton JM, Heyman J, Viswanathan H, Wreesmann VB, Hayes SM. 

Ann R Coll Surg Engl. 2019 Jan;101(1)

• Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma. 

Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C. 

Oncotarget. 2018 Apr 6;9(26):18198-18213.

• Complete nasal obstruction secondary to pacemaker insertion. 

Jones TL, Wreesmann VB, Nilssen E, Hilton J, Hayes SM. 

Ann R Coll Surg Engl. 2018 May;100(5)

• Optimization of the risk-benefit ratio of differentiated thyroid cancer treatment. 

Nasef HO, Nixon IJ, Wreesmann VB. Eur J Surg Oncol. 

2018 Mar;44(3):276-285. Review.

• The risk/benefit ratio of differentiated thyroid cancer treatment: Exploring treatment de-escalation. 

Wreesmann VB; on behalf of EJSO. 

Eur J Surg Oncol. 2018 Mar;44(3):275.

• Aggressive differentiated thyroid cancer. 

Janjua N, Wreesmann VB. 

Eur J Surg Oncol. 2018 Mar;44(3):367-377. Review.

• Role of extracapsular nodal spread and surgical margin status in defining high-risk head and neck squamous cell carcinoma and its treatment intensity. 

Wreesmann VB. 

International Journal of Head and Neck Surgery, April-June 2017; 8(2): 76-83.

• An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.              

Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. 

Thyroid. 2016 Mar;26(3):373-80.

• Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. 
•  
• Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gönen M, Carlson D, Ganly I, Shah JP, Ghossein R, Patel SG.

Head Neck. 2016 Apr;38 Suppl 1:E1192-9.

• Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer. 

Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP. 

Ann Surg Oncol. 2015 Jul 28.

• Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.
•  
• Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA.

Thyroid. 2015 May;25(5):503-8.

• Head and neck squamous cell carcinoma in young patients.

van Monsjou HS, Wreesmann VB, van den Brekel MW, Balm AJ. 

Oral Oncol. 2013 Dec;49(12):1097-102.

• Oral and oropharyngeal squamous cell carcinomas in young patients: The Netherlands Cancer Institute experience. 

van Monsjou HS, M Lopez-Yurda, M. Hauptmann, Balm AJ, van den Brekel MM, Wreesmann VB. 

Head Neck. 2013 Jan;35(1):94-102.

• Oropharyngeal squamous cell carcinoma: a unique disease on the rise?

van Monsjou HS, Balm AJ, van den Brekel MM, Wreesmann VB. 

Oral Oncol. 2010 Nov;46(11):780-5.

• Closure of tracheoesophageal fistula with prefabricated revascularized bilaminar radial forearm free flap.

Wreesmann VB, Smeele LE, Hilgers FJ, Lohuis PJ. 

Head Neck. 2009 Jun;31(6):838-42.

• Clinical impact of molecular analysis on thyroid cancer management.

Wreesmann VB, Singh B. 

Surg Oncol Clin N Am. 2008 Jan;17(1):1-35.

Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma. 

van den Broek GB, Wreesmann VB, van den Brekel MW, Rasch CR, Balm AJ, Rao PH. 

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4386-91.

• Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.

Wang SJ, Wreesmann VB, Bourguignon LY. 

Head Neck. 2007 Jun;29(6):550-8.

• Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
•  
• Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ.

ORL J Otorhinolaryngol Relat Spec. 2007;69(4):218-25. Epub 2007 Apr 4.

• Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.
•  
• Saltman B, Singh B, Hedvat CV, Wreesmann VB, Ghossein R.
•  
• Surgery. 2006 Dec;140(6):899-905; discussion 905-6.

• Repetitive endoscopic sinus surgery failure: a role for radical surgery?

Videler WJ, Wreesmann VB, van der Meulen FW, Knegt PP, Fokkens WJ. 

Otolaryngol Head Neck Surg. 2006 Apr;134(4):586-91.

• MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas.
•  
• Patel KN, Maghami E, Wreesmann VB, Shaha AR, Shah JP, Ghossein R, Singh B.
•  
• Surgery. 2005 Dec;138(6):994-1001; discussion 1001-2.

• Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities.

Wreesmann VB, Singh B. 

J Oral Pathol Med. 2005 Sep;34(8):449-59. Review.

• Molecular profiling of tumor progression in head and neck cancer.
•  
• Belbin TJ, Singh B, Smith RV, Socci ND, Wreesmann VB, Sanchez-Carbayo M, Masterson J, Patel S, Cordon-Cardo C, Prystowsky MB, Childs G.
•  
• Arch Otolaryngol Head Neck Surg. 2005 Jan;131(1):10-8.

• Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck.

Wreesmann VB, Shi W, Thaler HT, Poluri A, Kraus DH, Pfister D, Shaha AR, Shah JP, Rao PH, Singh B. 

J Clin Oncol. 2004 Oct 1;22(19):3965-72.

• Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.

Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

Genes Chromosomes Cancer. 2004 Aug;40(4):355-64.

• Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker.

Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein R, Singh B. 

Cancer Res. 2004 Jun 1;64(11):3780-9.

• Genetic abnormalities associated with nodal metastasis in head and neck cancer.

Wreesmann VB, Wang D, Goberdhan A, Prasad M, Ngai I, Schnaser EA, Sacks PG, Singh B. 

Head Neck. 2004 Jan;26(1):10-5.

• Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients.
•  
• Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, Huvos AG, Giampietro P, Levran O, Pujara K, Diotti R, Carlson D, Huryn LA, Auerbach AD, Singh B.
•  
• J Natl Cancer Inst. 2003 Nov 19;95(22):1718-21.

• Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure.

Singh B, Wreesmann VB, Pfister D, Poluri A, Shaha AR, Kraus D, Shah JP, Rao PH. 

BMC Genet. 2002 Nov 14;3:22. Epub 2002 Nov 14.

• Genome-wide appraisal of thyroid cancer progression.
•  
• Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B.
•  
• Am J Pathol. 2002 Nov;161(5):1549-56.

• Refractory chronic sinusitis: evaluation of symptom improvement after Denker’s procedure.
•  
• Wreesmann VB, Fokkens WJ, Knegt PP.
•  
• Otolaryngol Head Neck Surg. 2001 Nov;125(5):495-500.

• Inflammatory pseudotumour (inflammatory myofibroblastic tumour) of the pancreas: a report of six cases associated with obliterative phlebitis.
•  
• Wreesmann V, van Eijck CH, Naus DC, van Velthuysen ML, Jeekel J, Mooi WJ.
•  
• Histopathology. 2001 Feb;38(2):105-10.

• Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization.
•  
• Singh B, Lim D, Cigudosa JC, Ghossein R, Shaha AR, Poluri A, Wreesmann VB, Tuttle M, Shah JP, Rao PH.
•  
• Surgery. 2000 Dec;128(6):888-93;discussion 893-4.

Abstracts (Presentations at scientific meetings):

• Genome-wide screening for genetic prognostic factors in papillary thyroid carcinoma.
•  
• Wreesmann VB, Ghossein RA, Poluri A, Shaha AR, Tuttle RM, Shah JP Rao PH, Singh B.

Fifth International Conference on Head and Neck Cancer San Francisco, CA, July 2000.

• Hierarchical Clustering (HC): a Novel Approach to Evaluating the Prognostic Value of Laboratory Parameters in Patients (Pts) Undergoing Chemoradiation Treatment (CRT) for Advanced Laryngopharyngeal Carcinoma (LPC). 

Singh B, Pfister D, Wreesmann VB, Li R, Gogineni S, Bosl G, Hoffman RH, Shah JP, Rao PH. 

37th Annual Meeting of the American Society of Clinical Oncology; New Orleans LA, May 2001.

• Gain of 1q is unique to the tall cell variant of papillary thyroid cancer.

Wreesmann VB, Ghossein RA, Tuttle RM, Shaha AR, Robbins R, Shah JP, Rao PH, Singh B. 

73rd annual meeting of the American Thyroid Association, Washington D.C. November 2001.

• MUC1 is a target of 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer. 

Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Shah JP, Rao PH, Ghossein RG, Singh B. 

Annual Meeting of the New York Head and Neck Society, New York, NY, March 2002.

• Genome wide screening identified gains and losses as independent prognostic variables in patients with head and neck squamous cell carcinoma (HNSCC). 

Singh B, Wreesmann VB, Thaler HT, Shi W, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH. 

38th Annual Meeting of the American Society of Clinical Oncology; Orlando, Fl May 2002.

• p53 inactivation by human papillomavirus (HPV) in Fanconi anemia associated squamous cell carcinoma. 

Kutler DI, Goberdhan A, Wreesmann VB, Giampietro PF, Auerbach AD, Singh B. 

The Sixth Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer; Washington D.C.; October 2002.

• Identification of novel prognostic factors in head and neck squamous cell carcinoma. 
•  
• Wreesmann VB, Shi W, Thaler HT, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH, Singh B. 

7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

• Molecular profiling of aggressive papillary thyroid cancer: prognostic significance of MUC1 alterations. 

Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein RA, Singh B. 

7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

• Chromosomal aberrations in Fanconi anemia-associated squamous cell carcinomas differ from sporadic squamous cell carcinomas from the general population. 

Kutler DI, Rao PH, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

• Molecular classification of Fanconi anemia(FA)-associated head and neck squamous cell carcinoma (HNSCC) using oligonucleotide microarrays. 

Kutler DI, Ganly I, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

•  
• Genotyping follicular cell-derived thyroid neoplasia: a CGH study of 150 cases.

Wreesmann VB, Ghossein RA, Socci N, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

Sixth International Conference on Head and Neck Cancer, Washington DC, August 2004.

• Downregulation of Fanconi anemia genes in sporadic squamous cell carcinomas of the head and neck. 

Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ. 

208th meeting of the Netherlands Society of Otolaryngology-Head and Neck Surgery, Utrecht, April 7th 2006.

• Extracapsular nodal spread does not predict outcome in clinically node negative oral cavity squamous cell carcinoma. 

Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. 

AHNS 2013 Annual Meeting, April 10 & 11, 2013, Orlando Florida.

• Minor (<2mm) extracapsular spread is not an adverse predictor of outcome in metastatic squamous cell carcinoma of the oral cavity. 

Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. 

Presented at the AHNS 2014 Annual Meeting, July 2014, New York, New York.

Books, Chapters:

• Molecular Biology as applied to Head and Neck Oncology

Wreesmann VB, Singh B.

Stell and Maran's Textbook of Head and Neck Surgery and Oncology

Fifth Edition

Chapter, edited by John Watkinson and Ralph Gilbert

• Molecular-Cytogenetic Characterization of Head and Neck Cancer: Identification of molecular prognostic factors and targets of therapy

Wreesmann VB, Singh B.

Book, Amsterdam 2004

Reviewed in: Head and Neck: Volume 29, Issue 1, pages 82–83, January 2007

• Open Conservation Surgery for Laryngeal Cancer

Wreesmann VB, Ganly I

Scott-Brown's Otorhinolaryngology and Head and Neck Surgery, Eighth Edition

Chapter 27

CRC Press, Taylor-Francis Group, June 12th, 2018

• Molecular Oncology

Wreesmann V.B.

Self-Assessment in Head and Neck Surgery and Oncology, First Edition

Chapter 21

Elsevier 2014

Research grants:

Netherlands Cancer Institute “Startgeld” Grant 2008

Project: Fanconi anemia in head and neck cancer

Principal investigators: Wreesmann VB, van den Brekel MW, Balm AJM, Vens C.

Amount granted: 300.000 euro

Dr. Karin P. Q. Oomen, MD PhD

Consultant ENT Surgeon

www.andsurgeons.com

Date of Birth: 13 August 1977

Education

Biology, University of Utrecht — Sep 1995 – Sep 1996

Doctoral Degree in Medicine, University of Utrecht — Sep 1996 – Dec 2001

M.D., School of Medicine, University of Utrecht — Dec 2001 – Dec 2003

Senior House Officer, ENT Surgery, UMC Utrecht — Aug 2004 – Jan 2006

Residency, ENT Surgery, UMC Utrecht/Wilhelmina Children's Hospital — Feb 2006 – Feb 2011

PhD, Dept. of Anatomy & ENT Surgery, University of Utrecht — Feb 2011 – May 2011

Thesis: Anatomical and clinical appraisal of the pterygopalatine ganglion. Defended: 27 May 2011

Certifications

United States: ECFMG Certification — 1 May 2012

United States: Medical Licencing Examination (USMLE) — 1 May 2012

Step I: 203/84

Step IIa – Clinical Knowledge: 223/80

Step IIb – Clinical Skills: Pass

Surgical Fellowship

Paediatric Otolaryngology, Weill Cornell Medical College, New York, USA — Aug 2011 – Aug 2013

Professional Experience

Current Positions (since 2022)

Consultant ENT Surgeon & Owner, ANDSURGEONS, Andorra

Consultant ENT Surgeon, Clínica Omega Zeta & Clínica Som Salut, Andorra

Consultant ENT Surgeon, Centro Medico Teknon (Barcelona) Spain, Juaneda Clinics, Menorca, Spain, Avantmedic (Lleida), Spain

Consultant ENT Surgeon, Medinet, Portland Clinical, Imperial College London (Honorary Contract)

Previous Roles

Paediatric Otolaryngologist, UMC Utrecht/Wilhelmina Children’s Hospital — Feb 2014 – Feb 2016

Specialized in pediatric and adult ENT, with specific focus on voice, airway, cleft palate and laryngotracheal surgery.

Consultant ENT Surgeon, Queen Alexandra Hospital, Portsmouth, UK — Sep 2017 – December 2020

Licensure

United Kingdom: GMC #7511829 – Fully Registered, Specialist Registration

Netherlands: BIG #49061371701 – Physician (since Dec 2023)

Netherlands: RGS #1910932 – Otolaryngologist (since Feb 2011)

Spain: COMB #65907 (Barcelona)

Andorra: RPS #03255, Collegiat #913

Languages

Dutch: Native

English: Full Professional Proficiency

Spanish: Professional Working Proficiency

German: Professional Working Proficiency

French: Professional Working Proficiency

Catalan: Limited working proficiency

Medical Missions

Cleft lip and palate repair, Antigua, Guatemala — MMFC — Jun 2012

Selected Publications

Full list available at: https://pubmed.ncbi.nlm.nih.gov/?term=Oomen+k&sort=date

1. Endoscopic transmucosal direct puncture sclerotherapy for management of airway vascular malformations.

Oomen KP, Paramasivam S, Waner M, Niimi Y, Fifi JT, Berenstein A, O TM. 

Laryngoscope. 2016 Jan;126(1):205-11.

2. Thyroglossal duct cyst and ectopic thyroid: surgical management.

Oomen KP, Modi VK, Maddalozzo

J.Otolaryngol Clin North Am. 2015 Feb;48(1):15-27.

3. Epiglottopexy with and without lingual tonsillectomy.

Oomen KP, Modi VK.

Laryngoscope. 2014 Apr;124(4):1019-22.

4. Evidence-based practice: pediatric tonsillectomy.

Oomen KP, Modi VK, Stewart MG. 

Otolaryngol Clin North Am. 2012 Oct;45(5):1071-81

5. Effect of adenotonsillectomy on middle ear status in children.

Oomen KP, Rovers MM, van den Akker EH, van Staaij BK, Hoes AW, Schilder AG.

Laryngoscope. 2005 Apr;115(4):731-4.

Dr. Carlos Manuel Pollán Guisasola is a consultant ENT surgeon at Centro Médico Teknon and Hospital Germans Trias i Pujol in Barcelona. He specializes in endoscopic skull base surgery, head and neck oncology, and robotic surgery using the Da Vinci system. He earned his medical degree from the University of Santiago de Compostela. He completed his residency in Otorhinolaryngology through the MIR program at Vall d’Hebron University Hospital.

Dr. Pollán received advanced clinical training at the University of Pittsburgh and the University Hospital of Pisa. He leads the robotic head and neck surgery program at his hospitals. He is a faculty member at the ENT Teaching Unit of Germans Trias i Pujol. Dr. Pollán has published many peer-reviewed articles and frequently lectures at national and international conferences.

Areas of Interests

• Rhinoplasty
• Functional Nose Surgery
• Pediatric ENT Diseases

Education

• Hacettepe University English Faculty of Medicine
• Şişli Hamidiye Etfal Training and Research Hospital Ear Nose Throat Diseases

Experience

• Muş Bulanık State Hospital / Compulsory Service / 2016-2017
• Central Hospital Kozyatağı / 2017-2018
• University of Health Sciences Sultan Abdulhamid Han Training and Research Hospital / 2018-2022
• Istanbul Health and Technology University / 2022-Present

Dr. Erkan Vuralkan is a specialist in Otorhinolaryngology (ENT). He has worked at top hospitals such as Dışkapı Yıldırım Beyazıt Education and Research Hospital and Trabzon Kanuni Education and Research Hospital. He now practices at I.A.U VM MedicalPark Florya.

Dr. Vuralkan is a member of the Turkish Association of Otorhinolaryngology and the Turkish Association of Rhinology. He also supports scientific research through his work with the Journal of Clinical and Analytical Medicine and the Indian Journal of Otolaryngology and Head & Neck Surgery.

Dr. Claudiu Manea, MD, PhD, is a specialist in otorhinolaryngology (ENT) and an Associate Professor at the “Carol Davila” University of Medicine and Pharmacy in Bucharest. He has over 20 years of experience. He holds a PhD in Medical Sciences. He is known for endoscopic and laser surgery of the nose, paranasal sinuses, skull base, and larynx.

His practice focuses on endoscopic sinus and skull base surgery. He performs dacryocystorhinostomy, endoscopic and microscopic laryngeal surgery for voice disorders and tumors, and surgery for snoring and sleep apnea.

He completed advanced training in Romania, Italy, and Croatia. He leads the Department of Otorhinolaryngology at Ponderas Academic Hospital. He is a founding member of the Romanian Society of Rhinology. He is also a member of the European and International Rhinologic Societies. Awards: one international, two national.